Danielle Lienard

Brussels, BRU 1070, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The Role of Line-Field Confocal Optical Coherence Tomography in Detecting Extramammary Paget Disease Recurrences: A Pilot Diagnostic Study.

The Role of Line-Field Confocal Optical Coherence Tomography in Detecting Extramammary Paget Disease Recurrences: A Pilot Diagnostic Study.

Journal: Diagnostics (Basel, Switzerland)

Published: June 14, 2024

Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.

Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.

Journal: Frontiers in nephrology

Published: December 21, 2022

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.

Journal: Frontiers in nephrology

Published: September 11, 2022

Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.

Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 29, 2021

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.

Journal: Journal of translational medicine

Published: December 16, 2018

Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test.

Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test.

Journal: Melanoma research

Published: November 02, 2018

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma.

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma.

Journal: Melanoma research

Published: September 14, 2018

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.

Journal: Melanoma research

Published: December 12, 2017

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.

Journal: Journal of translational medicine

Published: April 20, 2016

Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma.

Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma.

Journal: Melanoma research

Published: February 03, 2015

Objective responses can be obtained by CTLA-4 inhibition in metastatic melanoma after BRAF inhibitor failure.

Objective responses can be obtained by CTLA-4 inhibition in metastatic melanoma after BRAF inhibitor failure.

Journal: Melanoma research

Published: November 15, 2014

Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma.

Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: March 19, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026